Cello Group plc (CLL) Stock Rating Reaffirmed by FinnCap


's stock had its "buy" rating reaffirmed by stock analysts at FinnCap in a research note issued to investors on Wednesday. They currently have a GBX 132 target price on the stock.



from Biotech News